found that metformin treatment induced intrahepatic cholestasis and liver injury in a minority number of type II diabetic patients possibly through inhibition of SIRT1 leading to elevated FOXA2 acetylation and transcriptional activity. The gene discussed is FOXA2; the disease is intrahepatic cholestasis.